MILWAUKEE, May 8, 2024 /PRNewswire/ -- The Centers for Medicare & Medicaid Services recently issued a decision to expand Medicare coverage for allogeneic hematopoietic stem cell transplants (HCT) for eligible Medicare patients with myelodysplastic syndromes (MDS), based on decades-long research led by investigators at the Medical College of Wisconsin (MCW) Cancer Center, in collaboration with investigators in the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) and advocacy experts at the American Society of Hematology (ASH), American Society for Transplantation and Cellular Therapy (ASTCT) and the National Marrow Donor Program (NMDP)..

密尔沃基，2024年5月8日/PRNewswire/-医疗保险和医疗补助服务中心最近发布了一项决定，根据威斯康星医学院（MCW）癌症中心研究人员领导的长达数十年的研究，与血液和骨髓移植临床试验网络（BMT-CTN）的研究人员以及美国血液学会（ASH）、美国移植与细胞治疗学会（ASTCT）和国家骨髓捐赠者计划（NMDP）的倡导专家合作，为符合条件的医疗保险骨髓增生异常综合征（MDS）患者扩大异基因造血干细胞移植（HCT）的医疗保险覆盖范围。。

MDS is a group of cancers that affect the body's ability to produce healthy blood cells. Allogeneic HCT is the only curative therapy for patients with MDS.

MDS是一组影响身体产生健康血细胞能力的癌症。同种异体HCT是MDS患者唯一的治疗方法。

'Until now, patients 65 and older with Medicare did not receive coverage for HCT, largely due to limited clinical research demonstrating that transplantations benefited patients in older age brackets (specifically Medicare beneficiaries) in the same way they benefitted younger patients,' said Douglas Rizzo, MD, MS, Senior Scientific Director of the Center for International Blood and Marrow Transplant Research (CIBMTR), a research affiliation of MCW and NMDP, and Cancer Service Line Director at Froedtert & the Medical College of Wisconsin.

“到目前为止，65岁及以上的医疗保险患者还没有获得HCT的保险，这主要是由于有限的临床研究表明，移植使老年患者（特别是医疗保险受益人）受益，就像他们使年轻患者受益一样，”医学博士、理学硕士道格拉斯·里佐（DouglasRizzo）说，他是MCW和NMDP的研究附属机构国际血液和骨髓移植研究中心（CIBMTR）的高级科学主任，也是Froedtert＆the Medical College of Wisconsin的癌症服务热线主任。

This challenge was further exacerbated since older adults were, consequently, overlooked as candidates for transplant because they did not have Medicare coverage for the procedure..

这一挑战进一步加剧，因为老年人因此被忽视为移植候选人，因为他们没有医疗保险覆盖程序。。

'We used our expertise in transplantation and the CIBMTR and BMT CTN research platforms to develop observational and interventional trials that would serve as a mechanism for gathering evidence to inform Medicare payment policy. For the first time in history, this made it possible for Medicare beneficiaries with MDS to enroll for treatment at transplant centers across the country and get coverage to support their care,' said Dr.

“我们利用我们在移植方面的专业知识以及CIBMTR和BMT CTN研究平台，开发了观察性和介入性试验，作为收集证据以告知医疗保险支付政策的机制。这是历史上第一次，这使得患有MDS的医疗保险受益人有可能在全国各地的移植中心登记接受治疗，并获得支持其护理的保险。

Rizzo. 'In the first three years after Medicare agreed to provide coverage conditional on participating in approved studies, the number of transplants more than quadrupled, and we started to see lifesaving outcomes that proved our belief that older patients would benefit from transplantation, just the same as younger patients.'  .

里佐。”在Medicare同意以参加批准的研究为条件提供覆盖的前三年，移植的数量增加了四倍多，我们开始看到挽救生命的结果，证明了我们的信念，即老年患者会从移植中受益，就像年轻患者一样。”。

Since then, studies on MDS led by MCW, and in collaboration with investigators from other institutions participating in the CIBMTR and BMT CTN, have provided access to transplants for nearly 6,000 Americans with MDS over the age of 65.

从那时起，由MCW领导的MDS研究，并与参与CIBMTR和BMT CTN的其他机构的研究人员合作，为近6000名65岁以上的MDS美国人提供了移植机会。

'We are proud to be part of this important work to bring greater HCT access to people on Medicare with MDS,' said Mohandas Narla, DSc, ASH President, and distinguished scientist at New York Blood Health Enterprises.

纽约血液健康企业（New York Blood Health Enterprises）杰出科学家、ASH总裁、DSc莫罕达斯·纳拉（Mohandas Narla）说：“我们很自豪能够参与这项重要工作，为MDS患者提供更多的HCT服务。”。

A final decision was recently made by Medicare in the form of a National Coverage Analysis Decision Memo to expand Medicare coverage for the affected population.

Medicare最近以国家覆盖率分析决策备忘录的形式做出了最终决定，以扩大受影响人群的Medicare覆盖率。

Full release: https://www.mcw.edu/newsroom/news-articles/mcw-cancer-center-leads-groundbreaking-change-in-medicare-policy-for-mds-patients-over-65

完全发布：https://www.mcw.edu/newsroom/news-articles/mcw-cancer-center-leads-groundbreaking-change-in-medicare-policy-for-mds-patients-over-65

SOURCE Medical College of Wisconsin

威斯康星州SOURCE医学院